| 1 | indirect | 3,644 |
| 2 | instrumental | 1,113 |
| 3 | electrospray | 272 |
| 4 | electrophoretic | 265 |
| 5 | -independent | 122 |
| 6 | transpulmonary | 97 |
| 7 | wet-mount | 65 |
| 8 | intangible | 43 |
| 9 | videofluoroscopic | 26 |
| 10 | array-based | 23 |
| 11 | cross-study | 23 |
| 12 | interfacility | 16 |
| 13 | acid-sensing | 15 |
| 14 | right-left | 14 |
| 15 | nondenaturing | 12 |
| 16 | dibutyl | 11 |
| 17 | igf-independent | 11 |
| 18 | cluster-specific | 10 |
| 19 | colossal | 10 |
| 20 | resource-based | 10 |
| 21 | double-label | 9 |
| 22 | 22f-inhibition | 7 |
| 23 | itemized | 7 |
| 24 | kalon | 7 |
| 25 | non-classic | 7 |
| 26 | q-sepharose | 7 |
| 27 | itraq-based | 6 |
| 28 | nanoelectrospray | 6 |
| 29 | antioxidant/pro-oxidant | 5 |
| 30 | full-scan | 5 |
| 31 | immuno-regulatory | 5 |
| 32 | lectin-based | 5 |
| 33 | non-descent | 5 |
| 34 | outcome-specific | 5 |
| 35 | 11β-hydroxyetiocholanolone | 4 |
| 36 | benzamidinium | 4 |
| 37 | di-n-butyl | 4 |
| 38 | diphenylene | 4 |
| 39 | electro-spray | 4 |
| 40 | enva-specific | 4 |
| 41 | estriol-containing | 4 |
| 42 | mono-2-ethyl-5-oxohexyl | 4 |
| 43 | nanostring | 4 |
| 44 | non-enzymic | 4 |
| 45 | non-material | 4 |
| 46 | orientation-dependent | 4 |
| 47 | penning | 4 |
| 48 | ultraslow | 4 |
| 49 | atp-gated | 3 |
| 50 | cnbr-activated | 3 |
| 51 | cyto-protective | 3 |
| 52 | diethanol | 3 |
| 53 | diisobutyl | 3 |
| 54 | diisononyl | 3 |
| 55 | diskettes | 3 |
| 56 | elevational | 3 |
| 57 | enzygnost | 3 |
| 58 | gc-flame | 3 |
| 59 | genotype® | 3 |
| 60 | high-acceleration | 3 |
| 61 | in-house-developed | 3 |
| 62 | mib-5 | 3 |
| 63 | mono-2-ethylhexyl | 3 |
| 64 | non-adverse | 3 |
| 65 | non-health-care | 3 |
| 66 | parker-palmer | 3 |
| 67 | proton-activated | 3 |
| 68 | statin-drug | 3 |
| 69 | temperature-correlated | 3 |
| 70 | unmediated | 3 |
| 71 | volume-sensitive | 3 |
| 72 | -δs | 2 |
| 73 | 1,1,3,3-tetracyano-2-ethoxypropenide | 2 |
| 74 | 12-ox-7-eth-l | 2 |
| 75 | 3-chloro-4-methylphenyl | 2 |
| 76 | 5,5-dimethyl-1-pyrroline | 2 |
| 77 | alkaline-modified | 2 |
| 78 | alpha-phenyl-n-tert-butyl | 2 |
| 79 | am-hydrolase | 2 |
| 80 | aminoimidazole | 2 |
| 81 | babies.for | 2 |
| 82 | binding-induced | 2 |
| 83 | calypte | 2 |
| 84 | color-mediated | 2 |
| 85 | cross-model | 2 |
| 86 | detection/electrospray | 2 |
| 87 | di-2-ethylhexyl | 2 |
| 88 | diethylhexyl | 2 |
| 89 | electrodialytic | 2 |
| 90 | enhanced-sensitivity | 2 |
| 91 | haar | 2 |
| 92 | hplc-electrospray | 2 |
| 93 | ice-breaking | 2 |
| 94 | ims-ft-ir | 2 |
| 95 | l-012 | 2 |
| 96 | lysine-11 | 2 |
| 97 | map-like | 2 |
| 98 | mixed-factors | 2 |
| 99 | mullikan | 2 |
| 100 | non-imputed | 2 |
| 101 | nonmetal | 2 |
| 102 | oxacarbenium | 2 |
| 103 | participants.in | 2 |
| 104 | patagioenas | 2 |
| 105 | pehpc | 2 |
| 106 | perflouro | 2 |
| 107 | pharmacy-related | 2 |
| 108 | pre-period | 2 |
| 109 | precursor-product | 2 |
| 110 | time-of | 2 |
| 111 | training/supervision | 2 |
| 112 | trimethylol | 2 |
| 113 | v1-v2 | 2 |
| 114 | variable.for | 2 |
| 115 | wrong-way-round | 2 |
| 116 | 'editorial | 1 |
| 117 | 'embodied | 1 |
| 118 | 'instrumental | 1 |
| 119 | 'preserving | 1 |
| 120 | 'wrong-way-round | 1 |
| 121 | 1,1-dibromo-1h-silole | 1 |
| 122 | 1,2,3-triazole-4-carboxyl | 1 |
| 123 | 1-dehydro-2,3,4-trimethoxybenzene | 1 |
| 124 | 1-dehydro-2-methoxybenzene | 1 |
| 125 | 1-dehydro-3,4-dimethoxybenzene | 1 |
| 126 | 1-trimethylsilyl,1-lithio-2,3,4,5-tetraphenyl-1-silacyclopentadienide | 1 |
| 127 | 1.55-14.84 | 1 |
| 128 | 10311.9 | 1 |
| 129 | 125i-keto-pgf1alpha | 1 |
| 130 | 149-210 | 1 |
| 131 | 18-f | 1 |
| 132 | 2,3,4-tri-o-benzoyl-alpha-l-rhamnopyranosyl | 1 |
| 133 | 2-amino-7-methyl-4-oxidopteridine-6-carboxyl-ate | 1 |
| 134 | 2-aryl-1,2,3-triazole | 1 |
| 135 | 2-azido-4-benzylamino-4n,3-o-carbonyl-2,4,6-trideoxy-d-galactopyranosyl | 1 |
| 136 | 2-methyl-3,4-dihydro-β-carbolinium | 1 |
| 137 | 3,4-cyclic | 1 |
| 138 | 3,6-di-o-sulfated | 1 |
| 139 | 3-o-linked | 1 |
| 140 | 3-r-hydroxymyristoyl | 1 |
| 141 | 3.22-27.46 | 1 |
| 142 | 3/bcl-2 | 1 |
| 143 | 3007.8 | 1 |
| 144 | 37,325 | 1 |
| 145 | 3963.6 | 1 |
| 146 | 4-chorobenzenesulfon-ate | 1 |
| 147 | 4-methoxybenzoyl | 1 |
| 148 | 60.128 | 1 |
| 149 | 627.4 | 1 |
| 150 | abscess-related | 1 |
| 151 | acetonitrile/methanol/water | 1 |
| 152 | acid-co-butyl | 1 |
| 153 | adamantylidene | 1 |
| 154 | annexin-v-specific | 1 |
| 155 | anti-candidial | 1 |
| 156 | antimicrobacterial | 1 |
| 157 | antipathological | 1 |
| 158 | antisuperoxide | 1 |
| 159 | aprx-screening | 1 |
| 160 | arduengo-type | 1 |
| 161 | arg-buffering | 1 |
| 162 | autocontrolled | 1 |
| 163 | benzanthronylnitrenium | 1 |
| 164 | benzylbuthyl | 1 |
| 165 | between-agent | 1 |
| 166 | between-quarter | 1 |
| 167 | bpd-specific | 1 |
| 168 | bridging/chelating | 1 |
| 169 | bronchitis-related | 1 |
| 170 | butylbenzyl | 1 |
| 171 | c-peptide-specific | 1 |
| 172 | c13h17n3o3 | 1 |
| 173 | c2-symmetrical | 1 |
| 174 | ca2+-permeable | 1 |
| 175 | cadmic | 1 |
| 176 | carbodiimide-mediated | 1 |
| 177 | career-time | 1 |
| 178 | carnitine/organic | 1 |
| 179 | carvedilol-metoprolol | 1 |
| 180 | categorical-level | 1 |
| 181 | cecf-stimulated | 1 |
| 182 | classmate | 1 |
| 183 | claudius | 1 |
| 184 | clinicial | 1 |
| 185 | compli- | 1 |
| 186 | copyrig | 1 |
| 187 | cost-effectiveness.in | 1 |
| 188 | cp-stimulated | 1 |
| 189 | creutz-taube | 1 |
| 190 | crosstrial | 1 |
| 191 | cu-abnormal | 1 |
| 192 | cn | 1 |
| 193 | dammarenyl | 1 |
| 194 | de52-cellulose | 1 |
| 195 | delns1-specific | 1 |
| 196 | di-cyclohexyl | 1 |
| 197 | dicotomized | 1 |
| 198 | diethylaminoethyl-cellulose | 1 |
| 199 | diisodecyl | 1 |
| 200 | diisooctyl | 1 |
| 201 | dl-serinium | 1 |
| 202 | délégation | 1 |
| 203 | economic-analysis | 1 |
| 204 | electrophoresis-electrospray | 1 |
| 205 | family-borne | 1 |
| 206 | fbp/sbpase-metal | 1 |
| 207 | field-assisted | 1 |
| 208 | fim™ | 1 |
| 209 | fluoride/chloride/hydride/methyl | 1 |
| 210 | fluoroaluminate | 1 |
| 211 | fructofuranosyl | 1 |
| 212 | growth.in | 1 |
| 213 | guanine-thymine | 1 |
| 214 | headache-index | 1 |
| 215 | healthcare/annual | 1 |
| 216 | heptachloro | 1 |
| 217 | hexadecylpyridinium | 1 |
| 218 | hg-xe | 1 |
| 219 | high-associated | 1 |
| 220 | hiv-1-resistance | 1 |
| 221 | hiv-positive.in | 1 |
| 222 | hogg1-modified | 1 |
| 223 | homocyclopropenium | 1 |
| 224 | hplc-peroxyoxalate | 1 |
| 225 | hplc/uv/electrospray | 1 |
| 226 | hsa-pcb153 | 1 |
| 227 | igm-capture | 1 |
| 228 | imminium | 1 |
| 229 | in-home/community | 1 |
| 230 | in-roup | 1 |
| 231 | inter-denomination | 1 |
| 232 | inter-instrument/inter-assay | 1 |
| 233 | intra-trial | 1 |
| 234 | intratreatment | 1 |
| 235 | ionization-time-of | 1 |
| 236 | ip3-induced | 1 |
| 237 | isocyanoborate | 1 |
| 238 | isoluminol-enhanced | 1 |
| 239 | itinérant | 1 |
| 240 | k-li | 1 |
| 241 | l-serinium | 1 |
| 242 | laser/desorption | 1 |
| 243 | lc-linear | 1 |
| 244 | lc-selective | 1 |
| 245 | lc/electrospray | 1 |
| 246 | ldl-relative | 1 |
| 247 | leukotoxin/leukotoxin | 1 |
| 248 | li-cl | 1 |
| 249 | light-gated | 1 |
| 250 | ltq-linear | 1 |
| 251 | lucigenin-derived | 1 |
| 252 | lys63-linked | 1 |
| 253 | m-77 | 1 |
| 254 | magnesium-permeable | 1 |
| 255 | maldi-quadropole | 1 |
| 256 | mc-yr. | 1 |
| 257 | mccb-rated | 1 |
| 258 | menthol-activated | 1 |
| 259 | methoxyisobutyl | 1 |
| 260 | methylguanidinium | 1 |
| 261 | model-to-model | 1 |
| 262 | mono-iso-butyl | 1 |
| 263 | monobenzyl | 1 |
| 264 | monobutyl | 1 |
| 265 | monoethanol | 1 |
| 266 | motor-functional | 1 |
| 267 | multiprobe/multiregion | 1 |
| 268 | mülliken | 1 |
| 269 | n-acyliminium | 1 |
| 270 | n-butylbenzyl | 1 |
| 271 | n-chlorosulfonyl | 1 |
| 272 | n-tert-butylsulfinyl | 1 |
| 273 | na-mri-in | 1 |
| 274 | nhc=n-heterocyclic | 1 |
| 275 | nirs-hec | 1 |
| 276 | nitrogen-stabilized | 1 |
| 277 | non-health-care-related | 1 |
| 278 | nonproject | 1 |
| 279 | nortricyclane-type | 1 |
| 280 | nppb-sensitive | 1 |
| 281 | o-aryloxide-nhc-ligated | 1 |
| 282 | o3c | 1 |
| 283 | on-drug/off-drug | 1 |
| 284 | oxo-ammonium | 1 |
| 285 | oxycurcumenol | 1 |
| 286 | patient-borne | 1 |
| 287 | pelletron | 1 |
| 288 | pentane-2,4-dionate | 1 |
| 289 | petromyzonamine | 1 |
| 290 | petromyzosterol | 1 |
| 291 | placebo.direct | 1 |
| 292 | placebo.head-to-head | 1 |
| 293 | poly-2-methoxyethyl | 1 |
| 294 | polylactosaminyl | 1 |
| 295 | post-stretching | 1 |
| 296 | pror | 1 |
| 297 | protein-affected | 1 |
| 298 | quadrupole-linear | 1 |
| 299 | recently-reduced | 1 |
| 300 | recovery.results | 1 |
| 301 | resolution-linear | 1 |
| 302 | respectively.direct | 1 |
| 303 | retro-claisen | 1 |
| 304 | rosca-type | 1 |
| 305 | récents | 1 |
| 306 | scale-local | 1 |
| 307 | sensor-equipped | 1 |
| 308 | silver-cyclodimethylsiloxane | 1 |
| 309 | simple/multiple | 1 |
| 310 | social/usual | 1 |
| 311 | spectrometry-selective | 1 |
| 312 | split-scalp | 1 |
| 313 | staffing/resource | 1 |
| 314 | static-groups | 1 |
| 315 | sulfoxilate | 1 |
| 316 | super-oxide | 1 |
| 317 | superdisarm | 1 |
| 318 | syn-β-hydroxy-α-vinyl | 1 |
| 319 | tandetron | 1 |
| 320 | technetium-based | 1 |
| 321 | thiophosphato-antimonite | 1 |
| 322 | thrombostatic | 1 |
| 323 | ti-u-th-pb | 1 |
| 324 | tri-tertbutylmethylphosphonium | 1 |
| 325 | trifluoro-methane-sulfonate | 1 |
| 326 | trimetal | 1 |
| 327 | tris/tricine | 1 |
| 328 | uc.the | 1 |
| 329 | uhplc-electrospray | 1 |
| 330 | unreimbursed | 1 |
| 331 | v-ge-as | 1 |
| 332 | vaginal-specimen | 1 |
| 333 | vdcabg | 1 |
| 334 | vinyliminium | 1 |
| 335 | women.in | 1 |
| 336 | yb-based | 1 |
| 337 | zincated | 1 |
| 338 | δ-hydroxy | 1 |
| 339 | π-radical | 1 |
| 1 | 'editorial | 1 |
| 2 | 'embodied | 1 |
| 3 | 'instrumental | 1 |
| 4 | 'preserving | 1 |
| 5 | 'wrong-way-round | 1 |
| 6 | -independent | 122 |
| 7 | -δs | 2 |
| 8 | 1,1,3,3-tetracyano-2-ethoxypropenide | 2 |
| 9 | 1,1-dibromo-1h-silole | 1 |
| 10 | 1,2,3-triazole-4-carboxyl | 1 |
| 11 | 1-dehydro-2,3,4-trimethoxybenzene | 1 |
| 12 | 1-dehydro-2-methoxybenzene | 1 |
| 13 | 1-dehydro-3,4-dimethoxybenzene | 1 |
| 14 | 1-trimethylsilyl,1-lithio-2,3,4,5-tetraphenyl-1-silacyclopentadienide | 1 |
| 15 | 1.55-14.84 | 1 |
| 16 | 10311.9 | 1 |
| 17 | 11β-hydroxyetiocholanolone | 4 |
| 18 | 12-ox-7-eth-l | 2 |
| 19 | 125i-keto-pgf1alpha | 1 |
| 20 | 149-210 | 1 |
| 21 | 18-f | 1 |
| 22 | 2,3,4-tri-o-benzoyl-alpha-l-rhamnopyranosyl | 1 |
| 23 | 2-amino-7-methyl-4-oxidopteridine-6-carboxyl-ate | 1 |
| 24 | 2-aryl-1,2,3-triazole | 1 |
| 25 | 2-azido-4-benzylamino-4n,3-o-carbonyl-2,4,6-trideoxy-d-galactopyranosyl | 1 |
| 26 | 2-methyl-3,4-dihydro-β-carbolinium | 1 |
| 27 | 22f-inhibition | 7 |
| 28 | 3,4-cyclic | 1 |
| 29 | 3,6-di-o-sulfated | 1 |
| 30 | 3-chloro-4-methylphenyl | 2 |
| 31 | 3-o-linked | 1 |
| 32 | 3-r-hydroxymyristoyl | 1 |
| 33 | 3.22-27.46 | 1 |
| 34 | 3/bcl-2 | 1 |
| 35 | 3007.8 | 1 |
| 36 | 37,325 | 1 |
| 37 | 3963.6 | 1 |
| 38 | 4-chorobenzenesulfon-ate | 1 |
| 39 | 4-methoxybenzoyl | 1 |
| 40 | 5,5-dimethyl-1-pyrroline | 2 |
| 41 | 60.128 | 1 |
| 42 | 627.4 | 1 |
| 43 | abscess-related | 1 |
| 44 | acetonitrile/methanol/water | 1 |
| 45 | acid-co-butyl | 1 |
| 46 | acid-sensing | 15 |
| 47 | adamantylidene | 1 |
| 48 | alkaline-modified | 2 |
| 49 | alpha-phenyl-n-tert-butyl | 2 |
| 50 | am-hydrolase | 2 |
| 51 | aminoimidazole | 2 |
| 52 | annexin-v-specific | 1 |
| 53 | anti-candidial | 1 |
| 54 | antimicrobacterial | 1 |
| 55 | antioxidant/pro-oxidant | 5 |
| 56 | antipathological | 1 |
| 57 | antisuperoxide | 1 |
| 58 | aprx-screening | 1 |
| 59 | arduengo-type | 1 |
| 60 | arg-buffering | 1 |
| 61 | array-based | 23 |
| 62 | atp-gated | 3 |
| 63 | autocontrolled | 1 |
| 64 | babies.for | 2 |
| 65 | benzamidinium | 4 |
| 66 | benzanthronylnitrenium | 1 |
| 67 | benzylbuthyl | 1 |
| 68 | between-agent | 1 |
| 69 | between-quarter | 1 |
| 70 | binding-induced | 2 |
| 71 | bpd-specific | 1 |
| 72 | bridging/chelating | 1 |
| 73 | bronchitis-related | 1 |
| 74 | butylbenzyl | 1 |
| 75 | c-peptide-specific | 1 |
| 76 | c13h17n3o3 | 1 |
| 77 | c2-symmetrical | 1 |
| 78 | ca2+-permeable | 1 |
| 79 | cadmic | 1 |
| 80 | calypte | 2 |
| 81 | carbodiimide-mediated | 1 |
| 82 | career-time | 1 |
| 83 | carnitine/organic | 1 |
| 84 | carvedilol-metoprolol | 1 |
| 85 | categorical-level | 1 |
| 86 | cecf-stimulated | 1 |
| 87 | classmate | 1 |
| 88 | claudius | 1 |
| 89 | clinicial | 1 |
| 90 | cluster-specific | 10 |
| 91 | cnbr-activated | 3 |
| 92 | color-mediated | 2 |
| 93 | colossal | 10 |
| 94 | compli- | 1 |
| 95 | copyrig | 1 |
| 96 | cost-effectiveness.in | 1 |
| 97 | cp-stimulated | 1 |
| 98 | creutz-taube | 1 |
| 99 | cross-model | 2 |
| 100 | cross-study | 23 |
| 101 | crosstrial | 1 |
| 102 | cu-abnormal | 1 |
| 103 | cyto-protective | 3 |
| 104 | cn | 1 |
| 105 | dammarenyl | 1 |
| 106 | de52-cellulose | 1 |
| 107 | delns1-specific | 1 |
| 108 | detection/electrospray | 2 |
| 109 | di-2-ethylhexyl | 2 |
| 110 | di-cyclohexyl | 1 |
| 111 | di-n-butyl | 4 |
| 112 | dibutyl | 11 |
| 113 | dicotomized | 1 |
| 114 | diethanol | 3 |
| 115 | diethylaminoethyl-cellulose | 1 |
| 116 | diethylhexyl | 2 |
| 117 | diisobutyl | 3 |
| 118 | diisodecyl | 1 |
| 119 | diisononyl | 3 |
| 120 | diisooctyl | 1 |
| 121 | diphenylene | 4 |
| 122 | diskettes | 3 |
| 123 | dl-serinium | 1 |
| 124 | double-label | 9 |
| 125 | délégation | 1 |
| 126 | economic-analysis | 1 |
| 127 | electro-spray | 4 |
| 128 | electrodialytic | 2 |
| 129 | electrophoresis-electrospray | 1 |
| 130 | electrophoretic | 265 |
| 131 | electrospray | 272 |
| 132 | elevational | 3 |
| 133 | enhanced-sensitivity | 2 |
| 134 | enva-specific | 4 |
| 135 | enzygnost | 3 |
| 136 | estriol-containing | 4 |
| 137 | family-borne | 1 |
| 138 | fbp/sbpase-metal | 1 |
| 139 | field-assisted | 1 |
| 140 | fim™ | 1 |
| 141 | fluoride/chloride/hydride/methyl | 1 |
| 142 | fluoroaluminate | 1 |
| 143 | fructofuranosyl | 1 |
| 144 | full-scan | 5 |
| 145 | gc-flame | 3 |
| 146 | genotype® | 3 |
| 147 | growth.in | 1 |
| 148 | guanine-thymine | 1 |
| 149 | haar | 2 |
| 150 | headache-index | 1 |
| 151 | healthcare/annual | 1 |
| 152 | heptachloro | 1 |
| 153 | hexadecylpyridinium | 1 |
| 154 | hg-xe | 1 |
| 155 | high-acceleration | 3 |
| 156 | high-associated | 1 |
| 157 | hiv-1-resistance | 1 |
| 158 | hiv-positive.in | 1 |
| 159 | hogg1-modified | 1 |
| 160 | homocyclopropenium | 1 |
| 161 | hplc-electrospray | 2 |
| 162 | hplc-peroxyoxalate | 1 |
| 163 | hplc/uv/electrospray | 1 |
| 164 | hsa-pcb153 | 1 |
| 165 | ice-breaking | 2 |
| 166 | igf-independent | 11 |
| 167 | igm-capture | 1 |
| 168 | imminium | 1 |
| 169 | immuno-regulatory | 5 |
| 170 | ims-ft-ir | 2 |
| 171 | in-home/community | 1 |
| 172 | in-house-developed | 3 |
| 173 | in-roup | 1 |
| 174 | indirect | 3,644 |
| 175 | instrumental | 1,113 |
| 176 | intangible | 43 |
| 177 | inter-denomination | 1 |
| 178 | inter-instrument/inter-assay | 1 |
| 179 | interfacility | 16 |
| 180 | intra-trial | 1 |
| 181 | intratreatment | 1 |
| 182 | ionization-time-of | 1 |
| 183 | ip3-induced | 1 |
| 184 | isocyanoborate | 1 |
| 185 | isoluminol-enhanced | 1 |
| 186 | itemized | 7 |
| 187 | itinérant | 1 |
| 188 | itraq-based | 6 |
| 189 | k-li | 1 |
| 190 | kalon | 7 |
| 191 | l-012 | 2 |
| 192 | l-serinium | 1 |
| 193 | laser/desorption | 1 |
| 194 | lc-linear | 1 |
| 195 | lc-selective | 1 |
| 196 | lc/electrospray | 1 |
| 197 | ldl-relative | 1 |
| 198 | lectin-based | 5 |
| 199 | leukotoxin/leukotoxin | 1 |
| 200 | li-cl | 1 |
| 201 | light-gated | 1 |
| 202 | ltq-linear | 1 |
| 203 | lucigenin-derived | 1 |
| 204 | lys63-linked | 1 |
| 205 | lysine-11 | 2 |
| 206 | m-77 | 1 |
| 207 | magnesium-permeable | 1 |
| 208 | maldi-quadropole | 1 |
| 209 | map-like | 2 |
| 210 | mc-yr. | 1 |
| 211 | mccb-rated | 1 |
| 212 | menthol-activated | 1 |
| 213 | methoxyisobutyl | 1 |
| 214 | methylguanidinium | 1 |
| 215 | mib-5 | 3 |
| 216 | mixed-factors | 2 |
| 217 | model-to-model | 1 |
| 218 | mono-2-ethyl-5-oxohexyl | 4 |
| 219 | mono-2-ethylhexyl | 3 |
| 220 | mono-iso-butyl | 1 |
| 221 | monobenzyl | 1 |
| 222 | monobutyl | 1 |
| 223 | monoethanol | 1 |
| 224 | motor-functional | 1 |
| 225 | mullikan | 2 |
| 226 | multiprobe/multiregion | 1 |
| 227 | mülliken | 1 |
| 228 | n-acyliminium | 1 |
| 229 | n-butylbenzyl | 1 |
| 230 | n-chlorosulfonyl | 1 |
| 231 | n-tert-butylsulfinyl | 1 |
| 232 | na-mri-in | 1 |
| 233 | nanoelectrospray | 6 |
| 234 | nanostring | 4 |
| 235 | nhc=n-heterocyclic | 1 |
| 236 | nirs-hec | 1 |
| 237 | nitrogen-stabilized | 1 |
| 238 | non-adverse | 3 |
| 239 | non-classic | 7 |
| 240 | non-descent | 5 |
| 241 | non-enzymic | 4 |
| 242 | non-health-care | 3 |
| 243 | non-health-care-related | 1 |
| 244 | non-imputed | 2 |
| 245 | non-material | 4 |
| 246 | nondenaturing | 12 |
| 247 | nonmetal | 2 |
| 248 | nonproject | 1 |
| 249 | nortricyclane-type | 1 |
| 250 | nppb-sensitive | 1 |
| 251 | o-aryloxide-nhc-ligated | 1 |
| 252 | o3c | 1 |
| 253 | on-drug/off-drug | 1 |
| 254 | orientation-dependent | 4 |
| 255 | outcome-specific | 5 |
| 256 | oxacarbenium | 2 |
| 257 | oxo-ammonium | 1 |
| 258 | oxycurcumenol | 1 |
| 259 | parker-palmer | 3 |
| 260 | participants.in | 2 |
| 261 | patagioenas | 2 |
| 262 | patient-borne | 1 |
| 263 | pehpc | 2 |
| 264 | pelletron | 1 |
| 265 | penning | 4 |
| 266 | pentane-2,4-dionate | 1 |
| 267 | perflouro | 2 |
| 268 | petromyzonamine | 1 |
| 269 | petromyzosterol | 1 |
| 270 | pharmacy-related | 2 |
| 271 | placebo.direct | 1 |
| 272 | placebo.head-to-head | 1 |
| 273 | poly-2-methoxyethyl | 1 |
| 274 | polylactosaminyl | 1 |
| 275 | post-stretching | 1 |
| 276 | pre-period | 2 |
| 277 | precursor-product | 2 |
| 278 | pror | 1 |
| 279 | protein-affected | 1 |
| 280 | proton-activated | 3 |
| 281 | q-sepharose | 7 |
| 282 | quadrupole-linear | 1 |
| 283 | recently-reduced | 1 |
| 284 | recovery.results | 1 |
| 285 | resolution-linear | 1 |
| 286 | resource-based | 10 |
| 287 | respectively.direct | 1 |
| 288 | retro-claisen | 1 |
| 289 | right-left | 14 |
| 290 | rosca-type | 1 |
| 291 | récents | 1 |
| 292 | scale-local | 1 |
| 293 | sensor-equipped | 1 |
| 294 | silver-cyclodimethylsiloxane | 1 |
| 295 | simple/multiple | 1 |
| 296 | social/usual | 1 |
| 297 | spectrometry-selective | 1 |
| 298 | split-scalp | 1 |
| 299 | staffing/resource | 1 |
| 300 | static-groups | 1 |
| 301 | statin-drug | 3 |
| 302 | sulfoxilate | 1 |
| 303 | super-oxide | 1 |
| 304 | superdisarm | 1 |
| 305 | syn-β-hydroxy-α-vinyl | 1 |
| 306 | tandetron | 1 |
| 307 | technetium-based | 1 |
| 308 | temperature-correlated | 3 |
| 309 | thiophosphato-antimonite | 1 |
| 310 | thrombostatic | 1 |
| 311 | ti-u-th-pb | 1 |
| 312 | time-of | 2 |
| 313 | training/supervision | 2 |
| 314 | transpulmonary | 97 |
| 315 | tri-tertbutylmethylphosphonium | 1 |
| 316 | trifluoro-methane-sulfonate | 1 |
| 317 | trimetal | 1 |
| 318 | trimethylol | 2 |
| 319 | tris/tricine | 1 |
| 320 | uc.the | 1 |
| 321 | uhplc-electrospray | 1 |
| 322 | ultraslow | 4 |
| 323 | unmediated | 3 |
| 324 | unreimbursed | 1 |
| 325 | v-ge-as | 1 |
| 326 | v1-v2 | 2 |
| 327 | vaginal-specimen | 1 |
| 328 | variable.for | 2 |
| 329 | vdcabg | 1 |
| 330 | videofluoroscopic | 26 |
| 331 | vinyliminium | 1 |
| 332 | volume-sensitive | 3 |
| 333 | wet-mount | 65 |
| 334 | women.in | 1 |
| 335 | wrong-way-round | 2 |
| 336 | yb-based | 1 |
| 337 | zincated | 1 |
| 338 | δ-hydroxy | 1 |
| 339 | π-radical | 1 |
| 1 | compli- | 1 |
| 2 | mc-yr. | 1 |
| 3 | 149-210 | 1 |
| 4 | lysine-11 | 2 |
| 5 | 3/bcl-2 | 1 |
| 6 | l-012 | 2 |
| 7 | v1-v2 | 2 |
| 8 | hsa-pcb153 | 1 |
| 9 | c13h17n3o3 | 1 |
| 10 | 627.4 | 1 |
| 11 | 1.55-14.84 | 1 |
| 12 | mib-5 | 3 |
| 13 | 37,325 | 1 |
| 14 | 3963.6 | 1 |
| 15 | 3.22-27.46 | 1 |
| 16 | m-77 | 1 |
| 17 | 3007.8 | 1 |
| 18 | 60.128 | 1 |
| 19 | 10311.9 | 1 |
| 20 | 125i-keto-pgf1alpha | 1 |
| 21 | ti-u-th-pb | 1 |
| 22 | o3c | 1 |
| 23 | nirs-hec | 1 |
| 24 | delns1-specific | 1 |
| 25 | enva-specific | 4 |
| 26 | bpd-specific | 1 |
| 27 | c-peptide-specific | 1 |
| 28 | outcome-specific | 5 |
| 29 | cluster-specific | 10 |
| 30 | annexin-v-specific | 1 |
| 31 | 3,4-cyclic | 1 |
| 32 | nhc=n-heterocyclic | 1 |
| 33 | cadmic | 1 |
| 34 | non-enzymic | 4 |
| 35 | carnitine/organic | 1 |
| 36 | videofluoroscopic | 26 |
| 37 | non-classic | 7 |
| 38 | thrombostatic | 1 |
| 39 | electrophoretic | 265 |
| 40 | electrodialytic | 2 |
| 41 | pehpc | 2 |
| 42 | placebo.head-to-head | 1 |
| 43 | isoluminol-enhanced | 1 |
| 44 | recently-reduced | 1 |
| 45 | ip3-induced | 1 |
| 46 | binding-induced | 2 |
| 47 | 'embodied | 1 |
| 48 | hogg1-modified | 1 |
| 49 | alkaline-modified | 2 |
| 50 | lys63-linked | 1 |
| 51 | 3-o-linked | 1 |
| 52 | autocontrolled | 1 |
| 53 | in-house-developed | 3 |
| 54 | sensor-equipped | 1 |
| 55 | yb-based | 1 |
| 56 | resource-based | 10 |
| 57 | technetium-based | 1 |
| 58 | lectin-based | 5 |
| 59 | itraq-based | 6 |
| 60 | array-based | 23 |
| 61 | unreimbursed | 1 |
| 62 | zincated | 1 |
| 63 | 3,6-di-o-sulfated | 1 |
| 64 | atp-gated | 3 |
| 65 | light-gated | 1 |
| 66 | o-aryloxide-nhc-ligated | 1 |
| 67 | high-associated | 1 |
| 68 | carbodiimide-mediated | 1 |
| 69 | color-mediated | 2 |
| 70 | unmediated | 3 |
| 71 | non-health-care-related | 1 |
| 72 | bronchitis-related | 1 |
| 73 | abscess-related | 1 |
| 74 | pharmacy-related | 2 |
| 75 | temperature-correlated | 3 |
| 76 | cecf-stimulated | 1 |
| 77 | cp-stimulated | 1 |
| 78 | mccb-rated | 1 |
| 79 | menthol-activated | 1 |
| 80 | proton-activated | 3 |
| 81 | cnbr-activated | 3 |
| 82 | protein-affected | 1 |
| 83 | field-assisted | 1 |
| 84 | non-imputed | 2 |
| 85 | lucigenin-derived | 1 |
| 86 | nitrogen-stabilized | 1 |
| 87 | itemized | 7 |
| 88 | dicotomized | 1 |
| 89 | wrong-way-round | 2 |
| 90 | 'wrong-way-round | 1 |
| 91 | pre-period | 2 |
| 92 | creutz-taube | 1 |
| 93 | hiv-1-resistance | 1 |
| 94 | staffing/resource | 1 |
| 95 | 1-trimethylsilyl,1-lithio-2,3,4,5-tetraphenyl-1-silacyclopentadienide | 1 |
| 96 | 1,1,3,3-tetracyano-2-ethoxypropenide | 2 |
| 97 | super-oxide | 1 |
| 98 | antisuperoxide | 1 |
| 99 | uc.the | 1 |
| 100 | map-like | 2 |
| 101 | ca2+-permeable | 1 |
| 102 | magnesium-permeable | 1 |
| 103 | intangible | 43 |
| 104 | 1,1-dibromo-1h-silole | 1 |
| 105 | maldi-quadropole | 1 |
| 106 | aminoimidazole | 2 |
| 107 | 2-aryl-1,2,3-triazole | 1 |
| 108 | simple/multiple | 1 |
| 109 | gc-flame | 3 |
| 110 | career-time | 1 |
| 111 | silver-cyclodimethylsiloxane | 1 |
| 112 | adamantylidene | 1 |
| 113 | diphenylene | 4 |
| 114 | 1-dehydro-2-methoxybenzene | 1 |
| 115 | 1-dehydro-3,4-dimethoxybenzene | 1 |
| 116 | 1-dehydro-2,3,4-trimethoxybenzene | 1 |
| 117 | tris/tricine | 1 |
| 118 | 5,5-dimethyl-1-pyrroline | 2 |
| 119 | petromyzonamine | 1 |
| 120 | guanine-thymine | 1 |
| 121 | 11β-hydroxyetiocholanolone | 4 |
| 122 | patient-borne | 1 |
| 123 | family-borne | 1 |
| 124 | rosca-type | 1 |
| 125 | nortricyclane-type | 1 |
| 126 | arduengo-type | 1 |
| 127 | non-health-care | 3 |
| 128 | igm-capture | 1 |
| 129 | am-hydrolase | 2 |
| 130 | de52-cellulose | 1 |
| 131 | diethylaminoethyl-cellulose | 1 |
| 132 | q-sepharose | 7 |
| 133 | non-adverse | 3 |
| 134 | 2-amino-7-methyl-4-oxidopteridine-6-carboxyl-ate | 1 |
| 135 | 4-chorobenzenesulfon-ate | 1 |
| 136 | hplc-peroxyoxalate | 1 |
| 137 | sulfoxilate | 1 |
| 138 | classmate | 1 |
| 139 | fluoroaluminate | 1 |
| 140 | trifluoro-methane-sulfonate | 1 |
| 141 | pentane-2,4-dionate | 1 |
| 142 | isocyanoborate | 1 |
| 143 | thiophosphato-antimonite | 1 |
| 144 | calypte | 2 |
| 145 | ldl-relative | 1 |
| 146 | lc-selective | 1 |
| 147 | spectrometry-selective | 1 |
| 148 | cyto-protective | 3 |
| 149 | nppb-sensitive | 1 |
| 150 | volume-sensitive | 3 |
| 151 | hg-xe | 1 |
| 152 | 18-f | 1 |
| 153 | time-of | 2 |
| 154 | ionization-time-of | 1 |
| 155 | vdcabg | 1 |
| 156 | copyrig | 1 |
| 157 | post-stretching | 1 |
| 158 | ice-breaking | 2 |
| 159 | aprx-screening | 1 |
| 160 | estriol-containing | 4 |
| 161 | penning | 4 |
| 162 | arg-buffering | 1 |
| 163 | nanostring | 4 |
| 164 | nondenaturing | 12 |
| 165 | acid-sensing | 15 |
| 166 | bridging/chelating | 1 |
| 167 | 'preserving | 1 |
| 168 | on-drug/off-drug | 1 |
| 169 | statin-drug | 3 |
| 170 | k-li | 1 |
| 171 | 12-ox-7-eth-l | 2 |
| 172 | π-radical | 1 |
| 173 | antipathological | 1 |
| 174 | c2-symmetrical | 1 |
| 175 | scale-local | 1 |
| 176 | clinicial | 1 |
| 177 | anti-candidial | 1 |
| 178 | non-material | 4 |
| 179 | antimicrobacterial | 1 |
| 180 | 'editorial | 1 |
| 181 | intra-trial | 1 |
| 182 | crosstrial | 1 |
| 183 | cu-abnormal | 1 |
| 184 | elevational | 3 |
| 185 | motor-functional | 1 |
| 186 | colossal | 10 |
| 187 | fbp/sbpase-metal | 1 |
| 188 | trimetal | 1 |
| 189 | nonmetal | 2 |
| 190 | instrumental | 1,113 |
| 191 | 'instrumental | 1 |
| 192 | healthcare/annual | 1 |
| 193 | social/usual | 1 |
| 194 | li-cl | 1 |
| 195 | double-label | 9 |
| 196 | model-to-model | 1 |
| 197 | cross-model | 2 |
| 198 | categorical-level | 1 |
| 199 | carvedilol-metoprolol | 1 |
| 200 | trimethylol | 2 |
| 201 | diethanol | 3 |
| 202 | monoethanol | 1 |
| 203 | oxycurcumenol | 1 |
| 204 | petromyzosterol | 1 |
| 205 | diisodecyl | 1 |
| 206 | fluoride/chloride/hydride/methyl | 1 |
| 207 | poly-2-methoxyethyl | 1 |
| 208 | benzylbuthyl | 1 |
| 209 | 3-chloro-4-methylphenyl | 2 |
| 210 | dammarenyl | 1 |
| 211 | n-tert-butylsulfinyl | 1 |
| 212 | polylactosaminyl | 1 |
| 213 | syn-β-hydroxy-α-vinyl | 1 |
| 214 | n-chlorosulfonyl | 1 |
| 215 | diisononyl | 3 |
| 216 | 3-r-hydroxymyristoyl | 1 |
| 217 | 4-methoxybenzoyl | 1 |
| 218 | fructofuranosyl | 1 |
| 219 | 2,3,4-tri-o-benzoyl-alpha-l-rhamnopyranosyl | 1 |
| 220 | 2-azido-4-benzylamino-4n,3-o-carbonyl-2,4,6-trideoxy-d-galactopyranosyl | 1 |
| 221 | diisooctyl | 1 |
| 222 | di-n-butyl | 4 |
| 223 | acid-co-butyl | 1 |
| 224 | mono-iso-butyl | 1 |
| 225 | alpha-phenyl-n-tert-butyl | 2 |
| 226 | dibutyl | 11 |
| 227 | monobutyl | 1 |
| 228 | diisobutyl | 3 |
| 229 | methoxyisobutyl | 1 |
| 230 | di-2-ethylhexyl | 2 |
| 231 | mono-2-ethylhexyl | 3 |
| 232 | diethylhexyl | 2 |
| 233 | di-cyclohexyl | 1 |
| 234 | mono-2-ethyl-5-oxohexyl | 4 |
| 235 | 1,2,3-triazole-4-carboxyl | 1 |
| 236 | butylbenzyl | 1 |
| 237 | n-butylbenzyl | 1 |
| 238 | monobenzyl | 1 |
| 239 | superdisarm | 1 |
| 240 | oxacarbenium | 2 |
| 241 | homocyclopropenium | 1 |
| 242 | benzanthronylnitrenium | 1 |
| 243 | benzamidinium | 4 |
| 244 | methylguanidinium | 1 |
| 245 | hexadecylpyridinium | 1 |
| 246 | 2-methyl-3,4-dihydro-β-carbolinium | 1 |
| 247 | n-acyliminium | 1 |
| 248 | vinyliminium | 1 |
| 249 | imminium | 1 |
| 250 | l-serinium | 1 |
| 251 | dl-serinium | 1 |
| 252 | tri-tertbutylmethylphosphonium | 1 |
| 253 | oxo-ammonium | 1 |
| 254 | full-scan | 5 |
| 255 | mullikan | 2 |
| 256 | mülliken | 1 |
| 257 | vaginal-specimen | 1 |
| 258 | retro-claisen | 1 |
| 259 | na-mri-in | 1 |
| 260 | hiv-positive.in | 1 |
| 261 | growth.in | 1 |
| 262 | women.in | 1 |
| 263 | cost-effectiveness.in | 1 |
| 264 | participants.in | 2 |
| 265 | leukotoxin/leukotoxin | 1 |
| 266 | multiprobe/multiregion | 1 |
| 267 | training/supervision | 2 |
| 268 | délégation | 1 |
| 269 | inter-denomination | 1 |
| 270 | high-acceleration | 3 |
| 271 | 22f-inhibition | 7 |
| 272 | laser/desorption | 1 |
| 273 | kalon | 7 |
| 274 | tandetron | 1 |
| 275 | pelletron | 1 |
| 276 | cn | 1 |
| 277 | heptachloro | 1 |
| 278 | perflouro | 2 |
| 279 | split-scalp | 1 |
| 280 | in-roup | 1 |
| 281 | haar | 2 |
| 282 | lc-linear | 1 |
| 283 | quadrupole-linear | 1 |
| 284 | resolution-linear | 1 |
| 285 | ltq-linear | 1 |
| 286 | parker-palmer | 3 |
| 287 | acetonitrile/methanol/water | 1 |
| 288 | between-quarter | 1 |
| 289 | ims-ft-ir | 2 |
| 290 | variable.for | 2 |
| 291 | babies.for | 2 |
| 292 | pror | 1 |
| 293 | v-ge-as | 1 |
| 294 | patagioenas | 2 |
| 295 | diskettes | 3 |
| 296 | economic-analysis | 1 |
| 297 | static-groups | 1 |
| 298 | mixed-factors | 2 |
| 299 | recovery.results | 1 |
| 300 | récents | 1 |
| 301 | claudius | 1 |
| 302 | -δs | 2 |
| 303 | nonproject | 1 |
| 304 | placebo.direct | 1 |
| 305 | respectively.direct | 1 |
| 306 | indirect | 3,644 |
| 307 | precursor-product | 2 |
| 308 | right-left | 14 |
| 309 | antioxidant/pro-oxidant | 5 |
| 310 | itinérant | 1 |
| 311 | non-descent | 5 |
| 312 | orientation-dependent | 4 |
| 313 | -independent | 122 |
| 314 | igf-independent | 11 |
| 315 | between-agent | 1 |
| 316 | intratreatment | 1 |
| 317 | wet-mount | 65 |
| 318 | enzygnost | 3 |
| 319 | ultraslow | 4 |
| 320 | headache-index | 1 |
| 321 | electro-spray | 4 |
| 322 | electrospray | 272 |
| 323 | hplc-electrospray | 2 |
| 324 | uhplc-electrospray | 1 |
| 325 | electrophoresis-electrospray | 1 |
| 326 | lc/electrospray | 1 |
| 327 | detection/electrospray | 2 |
| 328 | hplc/uv/electrospray | 1 |
| 329 | nanoelectrospray | 6 |
| 330 | inter-instrument/inter-assay | 1 |
| 331 | cross-study | 23 |
| 332 | transpulmonary | 97 |
| 333 | immuno-regulatory | 5 |
| 334 | interfacility | 16 |
| 335 | in-home/community | 1 |
| 336 | enhanced-sensitivity | 2 |
| 337 | δ-hydroxy | 1 |
| 338 | fim™ | 1 |
| 339 | genotype® | 3 |